II
InverseBio Inc.
SEC filingOther Technology · Cambridge, MA
Amount raised$500Ksold at filing
Total offering$600K$100K still open
Investors in the raise1count reported to the SEC
FiledApr 16, 2026first sale Apr 1, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Lawrence PhillipsExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.